智飞生物 (300122)

Chongqing Zhifei Biological Products Co.,Ltd.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexMSCI China A 50 IndexMSCI Component StocksCSI 100 IndexCSI 200 IndexCSI A100 IndexInnovative DrugsSTAR and ChiNext 50 IndexGuozheng Growth IndexLarge Cap GrowthCommitment Not to Reduce HoldingsEmerging Markets IndexPrivate Enterprises 100 IndexBiological ProductsBiological VaccinesPrivate Equity Heavy PositionsNon-Cyclical StocksHigh Accounts ReceivableChiNext Large CapChiNext 50 IndexChiNext IndexChiNext Blue ChipChiNext HealthcareChiNext TechShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexTech 100 IndexPharma & BiotechTechnology Leaders IndexStable Growth IndexSHS Technology Leaders IndexConsumer Services IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexSZSE 100 Equal Weight IndexYangtze River Protection IndexMid-cap High Beta IndexEqual Weight 90 IndexZhongchuang Equal Weight IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexJuchao 100 IndexChiNext Equal Weight IndexChiNext Composite IndexCCTV Innovation IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCSWD Life Sciences IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexSZSE Fundamental 60 IndexBiomedicine IndexCSSW Silk Road IndexExcellent Performance Strategy IndexGrowth 40 IndexChiNext Value IndexCOVID-19 PreventionHepatitis B VaccineCOVID-19 VaccineFTSE Russell ConceptLarge-cap Blue-chipAntiviralCSI 300 Non-cyclical IndexCNI Emerging Industries IndexSZSE Responsibility IndexCNI Responsibility IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexAdvanced Manufacturing IndexVaccine & Biotech IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSTAR Market & ChiNext 50 IndexSZSE Technology IndexSZSE Leaders IndexCSI 300 ESG Leading IndexSZSE 100 Return IndexChiNext Quality IndexSHS Innovative Drugs IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexESG 100 IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexChiNext Basic IndexSZSE Private Enterprises IndexHua Xia Bank ESG IndexCS Pharmaceutical Innovation IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSmart Select 300 ESG Leading IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexCNI A50 IndexPharmaceutical & Health 100 IndexCSI 300 Pharmaceutical IndexSME & ChiNext Q IndexCSI 700 IndexAH Economic Blue-chip IndexMid-small Cap IndexSZSE Fundamental 200 IndexZhongchuang High Beta IndexFundamental 200 IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexYangtze River 100 IndexChiNext High Beta IndexChiNext Manufacturing IndexCS Innovative Drugs IndexChiNext Growth IndexESG 300 IndexOrient Securities Competition IndexChina Economic Index GDPChiNext Return IndexJuchao Mid-cap IndexSZSE Fundamental 120 IndexChiNext Emerging IndexFundamental 600 IndexChiNext Growth IndexCSI 800 Cash Flow IndexStrategic Emerging Industries 100 IndexChongqing

K-Line Chart

No K-line data available

Company NameChongqing Zhifei Biological Products Co., Ltd.
Listing Date2010-09-28
Issue Price37.98RMB
Registered Capital239378.974710k RMB
Legal RepresentativeJiang Rensheng
Registered Address50th Floor, No. 1 Qingyun Road, Jiangbei District, Chongqing
IndustryBiological Products
Main BusinessResearch, development, production, and sales of vaccines and biological products.
Company ProfileChongqing Zhifei Biological Products Co., Ltd. (referred to as 'Zhifei' or 'Zhifei Biological') entered the biological products industry in 2002. With a registered capital of 1.6 billion yuan, it currently has over 2,000 employees and assets of 4.8 billion yuan. It was listed on the Shenzhen Stock Exchange in September 2010 (stock code: 300122), becoming the first privately-owned vaccine enterprise listed on the ChiNext board. The company has four wholly-owned subsidiaries and one equity-invested subsidiary, among which Beijing Zhifei Lvzhu Biological Pharmaceutical Co., Ltd. (referred to as 'Beijing Zhifei Lvzhu') and Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (referred to as 'Anhui Zhifei Longcom') are high-tech enterprises.

Stock Details

1. Key Indicators

  • Total Shares(W): 239378.97
  • Circulating A-Shares(W): 141430.62
  • Earnings Per Share(RMB): -0.5040
  • Net Assets Per Share(RMB): 12.2531
  • Operating Revenue(W RMB): 762740.69
  • Total Profit(W RMB): -151328.82
  • Net Profit Attributable to Parent(W RMB): -120641.48
  • Net Profit Growth Rate(%): -156.10
  • Weighted Return on Equity(%): -3.9900
  • Operating Cash Flow Per Share(RMB): 1.2470
  • Undistributed Profit Per Share(RMB): 10.7919
  • Capital Reserve Per Share(RMB): 0.0878

2. Main Business

The main business covers:

  • An international, full-industry-chain high-tech biopharmaceutical company integrating R&D, production, sales, distribution, import and export of vaccines and biological products.

3. Company Basic Information

  • Company Name: Chongqing Zhifei Biological Products Co., Ltd.
  • Listing Date: 2010-09-28
  • Industry: Pharmaceutical Manufacturing
  • Address: 50th Floor, No. 1 Yunlu Road, Jiangbei District, Chongqing
  • Website: www.zhifeishengwu.com
  • Company Profile: The Company was established through the overall transformation of the former Chongqing Zhifei Biological Products Co., Ltd. On August 15, 2009, the shareholders' meeting of the limited company agreed to legally transform Chongqing Zhifei Biological Products Co., Ltd. into Chongqing Zhifei Biological Products Co., Ltd. This change was based on the audit benchmark date of June 30, 2009. The net assets of the limited company confirmed by Zhongrui Yuehua Certified Public Accountants' Audit Report No. 2172 [2009] were RMB 374,761,827.09, which was converted into 360 million shares at a ratio of 1:0.9606. The balance of RMB 14,761,827.09 was transferred to capital reserve. All assets, liabilities and equity of the original limited company were inherited by the joint stock company. On September 7, 2009, the company registered with the Chongqing Administration for Industry and Commerce and obtained the "Business License" with registration number 500105000065802. The registered capital and paid-in capital were both RMB 360 million, and the legal representative was Jiang Rensheng.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3356.08 2.37
2 E Fund ChiNext ETF Fund 2415.90 1.71
3 Huatai-PineBridge CSI 300 ETF Fund 2042.08 1.44
4 Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Heli No.13 Private Securities Investment Fund Private Securities Investment Fund 1757.55 1.24
5 China Merchants Guozheng Bio-medicine Index Securities Investment Fund (LOF) Class A Fund 1615.47 1.14
6 E Fund CSI 300 Healthcare ETF Fund 1499.56 1.06
7 Tianhong Guozheng Bio-medicine ETF Fund 567.27 0.40
8 Guotai CSI Bio-medicine ETF Fund 382.47 0.27
9 E Fund CSI Wind Biotech Index Securities Investment Fund (LOF) Class A Fund 128.61 0.09
10 China Universal Guozheng Bio-medicine ETF Fund 103.76 0.07

5. Concept Sectors

  • Biological Vaccine
  • Hepatitis Concept
  • Innovative Drug
  • Weight Loss Drug
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • MSCI Constituent
  • Non-Cyclical Stock
  • Commitment Not to Reduce Holdings
  • High Accounts Receivable
  • Heavily Held by Private Funds
  • CSI 100
  • CSI SME 100
  • ChiNext Index
  • SZSE 100
  • SZSE 300
  • CSI 300
  • ChiNext 50
  • ChiNext 300
  • CSI 200
  • CSI 300 Non-Cyclical
  • ChiNext Blue Chip
  • ChiNext Large Cap
  • ChiNext Healthcare
  • STAR 50 & ChiNext 50
  • CSI 300 ESG
  • MSCI China A 50
  • CSI A 100

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information